Two more blood pressure drugs recalled for potential cancer risk
Teva Pharmaceuticals has launched a voluntary recall of two drugs used to treat high blood pressure as yet more medications face concerns over a possible cancer risk.
The recall affects all lots of combination tablets featuring the drugs amlodipine and valsartan and another combo drug featuring amlodipine, valsartan and hydrochlorothiazide.
The drugs could contain an impurity called N-nitroso-diethylamine, which has been classified as a possible human carcinogen, the FDA said. Patients taking either drug should contact their doctor or pharmacist.